Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...
We were so pleased to have the opportunity to address InformaMarkets’ 13 th Annual Pharma IPR Conference in Mumbai on legal challenges to polymorph patents. Patents covering one or more crystalline ...
Min Son of Hanol IP & Law reports on a ruling by the Supreme Court of Korea that will make it easier to obtain polymorph patents of known chemicals in the country Patenting polymorphs of crystalline ...
Jicheng Yang of Wanhuida Intellectual Property considers whether a notable Beijing Intellectual Property Court decision signals a change to assessing inventive step in polymorph patents in China On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results